In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma

References

• Avril N, Gourtsoyianni S, Reznek R. (2011). Gynecological cancers. Methods Mol Biol 727:171–89
   PubMedGoogle Scholar
• Barbu I, Crăiţoiu S, Simionescu CE, et al. (2013). Cd105 microvessels density, vegf, egfr-1 and c-erbb-2 and their prognostic correlation in different subtypes of cervical adenocarcinoma. Roman J Morphol Embryol = Rev Roumain Morphol Embryol 54:519–30
   PubMed Web of Science ®Google Scholar
• Ding D, Wang J, Zhu Z, et al. (2012). Tumor accumulation, penetration, and antitumor response of cisplatin-loaded gelatin/poly(acrylic acid) nanoparticles. ACS Appl Mater Interfaces 4:1838–46
   PubMed Web of Science ®Google Scholar
• Downing KH. (2000). Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics 1. Annu Rev Cell Dev Biol 16:89–111
   PubMed Web of Science ®Google Scholar
• Du K, Gong H-Y, Gong Z-M. (2014). Influence of serum vegf levels on therapeutic outcome and diagnosis/prognostic value in patients with cervical cancer. Asian Pac J Cancer Prev 15:8793–6
   PubMedGoogle Scholar
• Eifel PJ. (2006). Chemoradiotherapy in the treatment of cervical cancer. Semin Radiat Oncol 16:177–85
   PubMed Web of Science ®Google Scholar
• Estanqueiro M, Amaral MH, Conceicao J, et al. (2015). Nanotechnological carriers for cancer chemotherapy: the state of the art. Colloids Surf B Biointerfaces 126:631–48
   PubMed Web of Science ®Google Scholar
• Garrastazu Pereira G, Lawson AJ, Buttini F, et al. (2015). Loco-regional administration of nanomedicines for the treatment of lung cancer. Drug Deliv. [Epub ahead of print]. doi:10.3109/10717544.2015.1114047
   PubMed Web of Science ®Google Scholar
• Gong C, Deng S, Wu Q, et al. (2013). Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles. Biomaterials 34:1413–32
   PubMed Web of Science ®Google Scholar
• Gong C, Wang Y, Wang X, et al. (2010). Biodegradable self-assembled peg-pcl-peg micelles for hydrophobic drug delivery, Part 2: In vitro and in vivo toxicity evaluation. J Nanopart Res 13:721–31
   Web of Science ®Google Scholar
• Guo J, Gao X, Su L, et al. (2011). Aptamer-functionalized peg-plga nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 32:8010–20
   PubMed Web of Science ®Google Scholar
• Hafiz A, Abbasi AN, Ali N, et al. (2015). Frequency and severity of acute toxicity of pelvic radiotherapy for gynecological cancer. J Coll Phys Surg–Pakistan: JCPSP 25:802–6
   PubMed Web of Science ®Google Scholar
• Huang Y, Lu J, Gao X, et al. (2012). Peg-derivatized embelin as a dual functional carrier for the delivery of paclitaxel. Bioconjug Chem 23:1443–51
   PubMed Web of Science ®Google Scholar
• Jiang X, Xin H, Sha X, et al. (2011). Pegylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Int J Pharm 420:385–94
   PubMed Web of Science ®Google Scholar
• Jung J, Park S-J, Chung HK, et al. (2012). Polymeric nanoparticles containing taxanes enhance chemoradiotherapeutic efficacy in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 84:e77–83
   PubMed Web of Science ®Google Scholar
• Kataoka K, Harada A, Nagasaki Y. (2001). Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 47:113–31
   PubMed Web of Science ®Google Scholar
• Kumar BS, Saraswathi R, Kumar KV, et al. (2014). Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery. Drug Deliv 21:173–84
   PubMed Web of Science ®Google Scholar
• Lu J, Huang Y, Zhao W, et al. (2013a). Design and characterization of peg-derivatized vitamin e as a nanomicellar formulation for delivery of paclitaxel. Mol Pharm 10:2880–90
   PubMed Web of Science ®Google Scholar
• Lu J, Huang Y, Zhao W, et al. (2013b). Peg-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers. Biomaterials 34:1591–600
   PubMed Web of Science ®Google Scholar
• Lv PP, Ma YF, Yu R, et al. (2012). Targeted delivery of insoluble cargo (paclitaxel) by pegylated chitosan nanoparticles grafted with arg-gly-asp (rgd). Mol Pharm 9:1736–47
   PubMed Web of Science ®Google Scholar
• Makitie T, Summanen P, Tarkkanen A, et al. (1999). Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci 40:2471–80
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387–92
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. (2002). Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (taxol). J Control Release 80:129–44
   PubMed Web of Science ®Google Scholar
• Yee GP, de Souza P, Khachigian LM. (2013). Current and potential treatments for cervical cancer. Curr Cancer Drug Targets 13:205–20
   PubMed Web of Science ®Google Scholar
• Pasquier E, Carré M, Pourroy B, et al. (2004). Antiangiogenic activity of paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway. Mol Cancer Ther 3:1301–10
   PubMed Web of Science ®Google Scholar
• Pasquier E, Honore S, Pourroy B, et al. (2005). Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells. Cancer Res 65:2433–40
   PubMed Web of Science ®Google Scholar
• Passarella RJ, Spratt DE, van der Ende AE, et al. (2010). Targeted nanoparticles that deliver a sustained, specific release of paclitaxel to irradiated tumors. Cancer Res 70:4550–9
   PubMed Web of Science ®Google Scholar
• Schwartz EL. (2009). Antivascular actions of microtubule-binding drugs. Clin Cancer Res 15:2594–601
   PubMed Web of Science ®Google Scholar
• Seiwert TY, Salama JK, Vokes EE. (2007). The concurrent chemoradiation paradigm—general principles. Nat Clin Pract Oncol 4:86–100
   PubMedGoogle Scholar
• Shi C, Cao H, He W, et al. (2015). Novel drug delivery liposomes targeted with a fully human anti-vegf165 monoclonal antibody show superior antitumor efficacy in vivo. Biomed Pharmacother 73:48–57
   PubMed Web of Science ®Google Scholar
• Stepan D, Simionescu C, Stepan A, et al. (2012). Vegf and cd105 immunoexpression in squamous cervical carcinomas and associated precancerous lesions. Rom J Morphol Embryol 53:585–9
   PubMed Web of Science ®Google Scholar
• Terasima T, Tolmach LJ. (1963). X-ray sensitivity and DNA synthesis in synchronous populations of hela cells. Science 140:490–2
   PubMed Web of Science ®Google Scholar
• Wachsberger PR, Lawrence YR, Liu Y, et al. (2012). Epidermal growth factor receptor expression modulates antitumor efficacy of vandetanib or cediranib combined with radiotherapy in human glioblastoma xenografts. Int J Radiat Oncol Biol Phys 82:483–91
   PubMed Web of Science ®Google Scholar
• Wang C, Wang Y, Wang Y, et al. (2011). Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel. Int J Pharm 414:251–9
   PubMed Web of Science ®Google Scholar
• Wang X, Li J, Wang Y, et al. (2011). A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model. ACS Nano 5:6184–94
   PubMed Web of Science ®Google Scholar
• Wang ZY, Zhang H, Yang Y, et al. (2016). Preparation, characterization, and efficacy of thermosensitive liposomes containing paclitaxel. Drug Deliv 23:1222–31
   PubMed Web of Science ®Google Scholar
• Weaver BA. (2014). How taxol/paclitaxel kills cancer cells. Mol Biol Cell 25:2677–81
   PubMed Web of Science ®Google Scholar
• Wei X, Gong C, Gou M, et al. (2009). Biodegradable poly(epsilon-caprolactone)–poly(ethylene glycol) copolymers as drug delivery system. Int J Pharm 381:1–18
   PubMed Web of Science ®Google Scholar
• Werner ME, Copp JA, Karve S, et al. (2011). Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy. ACS Nano 5:8990–8
   PubMed Web of Science ®Google Scholar
• Werner ME, Cummings ND, Sethi M, et al. (2013). Preclinical evaluation of genexol-pm, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 86:463–8
   PubMed Web of Science ®Google Scholar
• Wu Z, Zou X, Yang L, et al. (2014). Thermosensitive hydrogel used in dual drug delivery system with paclitaxel-loaded micelles for in situ treatment of lung cancer. Colloids Surf B Biointerfaces 122:90–8
   PubMed Web of Science ®Google Scholar
• Xie Z, Guan H, Chen X, et al. (2007). A novel polymer-paclitaxel conjugate based on amphiphilic triblock copolymer. J Control Release 117:210–16
   PubMed Web of Science ®Google Scholar
• Xin H, Chen L, Gu J, et al. (2010). Enhanced anti-glioblastoma efficacy by ptx-loaded pegylated poly(ɛ-caprolactone) nanoparticles: in vitro and in vivo evaluation. Int J Pharm 402:238–47
   PubMed Web of Science ®Google Scholar
• Xu Z, Liu S, Kang Y, et al. (2015). Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy. Nanoscale 7:5859–68
   PubMed Web of Science ®Google Scholar
• Yang D, Van S, Jiang X, et al. (2011). Novel free paclitaxel-loaded poly(l-γ-glutamylglutamine)-paclitaxel nanoparticles. Int J Nanomedicine 6:85–91
   PubMed Web of Science ®Google Scholar
• Yoshizawa Y, Ogawara K, Fushimi A, et al. (2012). Deeper penetration into tumor tissues and enhanced in vivo antitumor activity of liposomal paclitaxel by pretreatment with angiogenesis inhibitor su5416. Mol Pharm 9:3486–94
   PubMed Web of Science ®Google Scholar
• You H, Fu S, Qin X, et al. (2016). A study of the synergistic effect of folate-decorated polymeric micelles incorporating hydroxycamptothecin with radiotherapy on xenografted human cervical carcinoma. Colloids Surf B Biointerfaces 140:150–60
   PubMed Web of Science ®Google Scholar
• Yu DH, Lu Q, Xie J, et al. (2010). Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature. Biomaterials 31:2278–92
   PubMed Web of Science ®Google Scholar
• Zhang P, Hu L, Yin Q, et al. (2012). Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: synthesis, preparation and in vivo evaluation. J Control Release 159:429–34
   PubMed Web of Science ®Google Scholar
• Zhang P, Huang Y, Liu H, et al. (2014). A peg-fmoc conjugate as a nanocarrier for paclitaxel. Biomaterials 35:7146–56
   PubMed Web of Science ®Google Scholar
• Zhang Z, Feng SS. (2006). Nanoparticles of poly(lactide)/vitamin e tpgs copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. Biomaterials 27:262–70
   PubMed Web of Science ®Google Scholar
• Zhou J, Wang L, Xu X, et al. (2012). Antitumor activity of endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft models. Oncol Lett 4:976–80
   PubMed Web of Science ®Google Scholar